492
Participants
Start Date
February 28, 2005
Aprepitant
Ondansetron
GW679769
Dexamethasone
GSK Investigational Site, Taipei
GSK Investigational Site, Taipei
GSK Investigational Site, Tao Yuan County
GSK Investigational Site, Quezon City
GSK Investigational Site, Budapest
GSK Investigational Site, Taft Avenue, Manila
GSK Investigational Site, Edegem
GSK Investigational Site, Leuven
GSK Investigational Site, Liège
GSK Investigational Site, Székesfehérvár
GSK Investigational Site, Ghent
GSK Investigational Site, Zagreb
GSK Investigational Site, Prague
GSK Investigational Site, Casalpusterlengo (LO)
GSK Investigational Site, Durango
GSK Investigational Site, Karachi
GSK Investigational Site, Pisa
GSK Investigational Site, Napoli
GSK Investigational Site, Benevento
GSK Investigational Site, Mérida
GSK Investigational Site, Singapore
GSK Investigational Site, Santiago
GSK Investigational Site, Capital Federal
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Salzburg
GSK Investigational Site, Vienna
GSK Investigational Site, Vienna
GSK Investigational Site, Santiago
GSK Investigational Site, Shatin, N.T.
GSK Investigational Site, Lahore
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Ostrava - Poruba
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Sassari
GSK Investigational Site, Perugia
GSK Investigational Site, Amsterdam
GSK Investigational Site, Amsterdam
GSK Investigational Site, Arnhem
GSK Investigational Site, Rotterdam
GSK Investigational Site, Utrecht
GSK Investigational Site, Callao
GSK Investigational Site, Bydogoszcz
GSK Investigational Site, Krakow
GSK Investigational Site, Poznan
GSK Investigational Site, Poznan
GSK Investigational Site, Bucharest
GSK Investigational Site, Košice
GSK Investigational Site, Nitra
Lead Sponsor
GlaxoSmithKline
INDUSTRY